RHOJ and neoplasm: To investigate whether RHOJ contributes to EMT-associated resistance to therapy in skin SCCs, we first assessed whether short hairpin RNA (shRNA)-mediated Rhoj knockdown (KD) sensitized EMT tumour cells to chemotherapy.